Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;6(5):96-8.

In vitro Evaluation of Antibacterial Efficacy of Pineapple Extract (Bromelain) on Periodontal Pathogens

N C Praveen  1 , A Rajesh  2 , Manish Madan  3 , Vishwajit Rampratap Chaurasia  4 , Neel V Hiremath  5 , Akanksha Manmohan Sharma  6
Affiliations

In vitro Evaluation of Antibacterial Efficacy of Pineapple Extract (Bromelain) on Periodontal Pathogens

N C Praveen et al. J Int Oral Health. 2014 Sep.

Abstract

Background: Periodontitis is an inflammatory disease resulting in the destruction of periodontal tissues. Various treatment modalities have been tried in the form of mechanical therapy and surgical therapy. Antimicrobial agents have been used as a monotherapy and as an adjunct with mechanical debridement. Various plant extracts have been used as antibacterial agents. Pineapple extract (bromelian) is one such agent. Hence this study was conducted to assess the antibacterial efficacy of bromelain on both aerobic and anaerobic periodontal microorganisms. The aim was to assess the antibacterial efficacy of bromelain on both aerobic and anaerobic periodontal microorganisms.

Materials and methods: Minimum inhibitory concentration (MIC) of bromelain was tested on isolated strains of Streptococcus mutans, Enterococcus fecalis Aggregatibacter actinomycetemcomitans (Aa), and Porphyromonas gingivalis (Pg) using serial dilution broth method.

Results: S. mutans showed sensitivity at the lowest concentration of 2 mg/ml as compared to E fecalis (31.25 mg/ml) while Pgingivalis showed sensitivity at the lowest concentration of 4.15 mg/ml as compared to Aa (16.6 mg/ml).

Conclusion: Bromelain exerts an antibacterial effect against potent periodontal pathogens; hence, it may be used as an antibacterial agent. However, further trial has to be conducted to validate this result.

Keywords: Aggregatibacter actinomycetemcomitans; Enterococcus fecalis periodontitis; Porphyromonas gingivalis; Streptococcus mutans; bromelain.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None

References

    1. Shklar G, Carranza FA. Carranza's Clinical Periodontology. In: Newman MG, Takei HH, Carranza FA, Klokkevold PR, editors. St. Louis, Missouri: Saunders Elsevier; 2002.
    1. Fleming TF. Periodontitis. Ann Periodontal. 1999;4:32–37.
    1. Pihlstrom BL. Periodontology for the General Practitioner, Periodontal. 2000-2001;25(1):1–25.
    1. Socransky SS, Haffajee AD. Microbial mechanisms in the pathogenesis of destructive periodontal diseases: A critical assessment. J Periodontal Res. 1991;26(3 Pt 2):195–212. - PubMed
    1. Marsh PD. Microbial ecology of dental plaque and its significance in health and disease. Adv Dent Res. 1994;8(2):263–71. - PubMed

LinkOut - more resources